Skip to main content
OpenTrials

Clinical trial condition

Waldenstrom Macroglobulinemia

Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.

397 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Waldenstrom Macroglobulinemia trial results

Not yet recruiting

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

NCT07474961

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Copenhagen University Hospital - Rigshospitalet Copenhagen, Greater Copenhagen Area, Denmark
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus, Denmark
  • Odense University Hospital Odense, Denmark
View Trial Details
Not yet recruiting

A Phase II Clinical Study of Zanubrutinib Combined With Four Cycles of CD20 Monoclonal Antibody and Reduced-Dose Bendamustine in the Treatment of Untreated Waldenström Macroglobulinemia

NCT07259122

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • China Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China
  • Institute of Hematology & Blood Diseases Hospital, China Tianjin, Tianjin Municipality, China
View Trial Details
Not yet recruiting

Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia

NCT06547866

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AMIENS - CH Amiens Picardie Site Sud Amiens, France
  • Angers Chu Angers, France
  • ANNECY - CH Annecy Genevois Annecy, France
  • ARGENTEUIL - Centre hospitalier Victor Dupouy Argenteuil, France
View all 37 locations
View Trial Details
Enrolling by invitation

Watch and Wait or Worry and Wait in Indolent Lymphoma

NCT07173790

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations
  • Samsung Medical Center Seoul, Gangnam-gu, South Korea
  • Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea
  • Seoul National University Hospital Seoul, Jongno-gu, South Korea
  • The Catholic University of Korea Seoul, Seocho-gu, South Korea
View Trial Details
Active, not recruiting

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

NCT02180724

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Research Site Santa Barbara, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Minneapolis, Minnesota, United States
View all 38 locations
View Trial Details

Related conditions